highly significantp < 0.001
If there is a highly significant (p < 0.001) difference in any primary outcome a panel comprising the researchers and Free State Department of Health managers will meet to discuss whether to terminate the trial.
If there is a highly significant (p < 0.001) difference in any primary outcome a panel comprising the researchers and Free State Department of Health managers will meet to discuss whether to terminate the trial.